Clinical Trials Directory

Trials / Completed

CompletedNCT02472340

Mitophagy and Autophagy in Elderly Subjects

Assessment and Reproducibility of Mitochondrial Function and Mitophagy Measurements in Human Muscle Tissue of Active and Pre Frail Elderly Males

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Amazentis SA · Industry
Sex
All
Age
61 Years – 85 Years
Healthy volunteers
Accepted

Summary

In recent years, evidence has shown that mitochondrial dysfunction plays an important role in the development of age-related muscle decline that may lead to frailty. During aging, there is a progressive reduction in the cell's capacity to eliminate its dysfunctional elements by autophagy, as evidenced by the accumulation of oxidative damage and mutations in mitochondria and by the decrease in autophagic flux. In fact, it has been demonstrated that dysfunctional mitochondria can be specifically targeted for elimination by autophagy, a process that has been termed mitophagy. A major challenge in the clinic today is in the lack of validated tools, including biomarkers, to assess the decline in mitochondrial health associated with an impairment in muscle function. In the present study, the investigators will employ a battery of established and exploratory tests (clinical, physiological and molecular) to assess in vivo mitochondrial function and more specifically, the levels of mitophagy and autophagy, in the muscle of healthy and pre-frail elderly. It is anticipated that the results of this study will facilitate the rapid translation of interventions targeting mitophagy and autophagy for the improvement of muscle function.

Conditions

Interventions

TypeNameDescription
PROCEDUREMuscle BiopsyMuscle Biopsy

Timeline

Start date
2015-06-01
Primary completion
2016-04-01
Completion
2016-07-01
First posted
2015-06-15
Last updated
2016-08-01

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02472340. Inclusion in this directory is not an endorsement.